Second Dose of Scorpion Antivenom in Children with Indian Red Scorpion (Mesobuthus tamulus) Sting Envenomation

Indian Pediatr. 2018 Apr 15;55(4):315-318. Epub 2018 Feb 9.

Abstract

Objective: To study the effect of the second dose of scorpion antivenom in children with non-resolving or worsening scorpion sting envenomation.

Methods: 72 children aged ≤12 years with scorpion sting envenomation grade 2 and above were enrolled. 61 received the first dose of three vials of antivenom at admission (group A). Children with persistent/worsening envenomation at 6 hours received the second dose (group B). The time required for resolution of autonomic symptoms, myocardial dysfunction, predictors of the second dose and side effects were studied.

Results: The mean time taken for resolution of autonomic symptoms were similar in GroupA and B (4.1 vs. 5.3 hours, P=0.452), and of myocardial dysfunction was shorter in Group A (10.8 vs. 37.6 hours, P=0.019). On regression analysis, abnormal echocardiography at admission was found to be a significant predictor of the second dose (OR=27.6, 95% CI, 4.7-162.5; P=<0.001).

Conclusion: Children with severe scorpion sting envenomation with abnormal echocardiography may require a higher dose of scorpion antivenom.

Publication types

  • Clinical Trial

MeSH terms

  • Antivenins / administration & dosage*
  • Antivenins / therapeutic use
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Infant
  • Male
  • Prospective Studies
  • Scorpion Stings / diagnosis
  • Scorpion Stings / drug therapy*
  • Scorpion Stings / physiopathology
  • Scorpion Venoms*

Substances

  • Antivenins
  • Scorpion Venoms